Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Clear Cell × Vemurafenib × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 3 Wilms Tumor 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Central Nervous System Neoplasms 2 Xanthogranuloma, Juvenile 1 Sarcoma, Clear Cell 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Medulloblastoma 1 Histiocytic Sarcoma 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 4 Topotecan 3 Ifosfamide 3 Doxorubicin 3 seclidemstat 2 pazopanib 2 Biopsy 2 tebentafusp 1 selinexor 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 devimistat 1 cobimetinib 1 atezolizumab 1 Zoledronic Acid 1 X-Rays 1 Vemurafenib 1 Sunitinib 1 Specimen Handling 1 Sirolimus 1 Simvastatin 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Radiation 1 Proton Therapy 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02968303 2020-06-05

COWBOY

Radboud University Medical Center

Phase 2 Unknown

Sarcoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡